Skip to main content

Table 1 Top 5 by Drug Sales, 2002

From: Medicines and vaccines for the world's poorest: Is there any prospect for public-private cooperation?

Company

Pharma. Revenue* ($ bn)

Net Profit ($ bn)

R&D ($ bn)

Pfizer

28.29

9.13

5.18

GSK

27.06

6.96

4.11

Merck

20.13

7.15

2.67

AstraZeneca

17.84

2.84

3.07

Johnson & Johnson

17.15

6.6

3.96

  1. * Most firms have income from other products as well; so total income exceeds pharmaceutical income
Back to article page

Globalization and Health

ISSN: 1744-8603